News
GLG Pharma’s STAT3 Signaling Inhibitor Selected for NCI’s PREVENT Cancer Preclinical Drug Development Program
Jupiter, Florida July 16, 2013- GLG Pharma, LLC announces scientific and financial resources of the PREVENT Cancer program of the National Cancer Institute of the NIH have been approved to study...
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy —Data Presented at AED Xll Meeting Confirms INS001 Appears Safe and Well Tolerated...
Exciting News From The Florida Institute
Issue 7 Ceremonial Bill Signing Celebrates Renewed Seed Funding for Florida Startups Rep. Ritch Workman, DEO Executive Director Jesse Panuccio, Dean Minardi, Gov. Rick Scott,...
- Articles |
Garmor Inc. to start manufacturing graphene, 'wonder material,' in August
Orlando Business Journal, July 11, 2013.Written by Aboraham Aboraya Garmor Inc. to Start Manufacturing Graphene, "Wonder Material," in August Come Aug. 1, Garmor Inc. will begin production of a...
Florida Institute Funds ClearSpec Medical
Boca Raton- Based ClearSpec Medical Receives Florida Institute Funding Seed Funds to Advance Device Development and Commercialization Efforts Gainesville and Boca Raton, FL – July 11, 2013 - The...